XENE
Price:
$52.1
Market Cap:
$4.11B
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and advancing innovative treatments for individuals living with neurological disorders. The company operates primarily from its headquarters in Burnaby, Canada. Its robust clinical pipeline showcases several promising candidates: XEN496, an activator of Kv7 potassium channels, is currently in Phase III clinical trials for KCNQ2 developmental and epileptic encephalopathy. Another Kv7 potassium channel activator, XEN1101, is progressing through Phase II trials, targeting epilepsy and a range of other neurological conditions. The portfolio also includes NBI-921352, a selective inhibitor of the Nav1...[Read more]
Industry
Biotechnology
IPO Date
2014-11-05
Stock Exchange
NASDAQ
Ticker
XENE
According to Xenon Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -11.09. This represents a change of 20.24% compared to the average of -9.22 of the last 4 quarters.
The mean historical PE Ratio of Xenon Pharmaceuticals Inc. over the last ten years is -11.35. The current -11.09 PE Ratio has changed 9.67% with respect to the historical average. Over the past ten years (40 quarters), XENE's PE Ratio was at its highest in in the December 2019 quarter at 0. The PE Ratio was at its lowest in in the June 2020 quarter at -626.63.
Average
-11.35
Median
-11.65
Minimum
-19.04
Maximum
-1.66
Discovering the peaks and valleys of Xenon Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 130.09%
Maximum Annual PE Ratio = -1.66
Minimum Annual Increase = -68.05%
Minimum Annual PE Ratio = -19.04
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -10.27 | -21.19% |
| 2024 | -13.03 | -22.86% |
| 2023 | -16.89 | -11.29% |
| 2022 | -19.04 | 10.20% |
| 2021 | -17.28 | -6.21% |
| 2020 | -18.42 | 125.34% |
| 2019 | -8.18 | 130.09% |
| 2018 | -3.55 | 114.35% |
| 2017 | -1.66 | -68.05% |
| 2016 | -5.19 | -28.84% |
The current PE Ratio of Xenon Pharmaceuticals Inc. (XENE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-13.40
5-year avg
-15.30
10-year avg
-11.35
Xenon Pharmaceuticals Inc.’s PE Ratio is greater than Centessa Pharmaceuticals plc (-24.33), greater than Apogee Therapeutics, Inc. (-22.41), less than Ascentage Pharma Group International (-8.95), less than Ultragenyx Pharmaceutical Inc. (-4.02), greater than Celcuity Inc. (-25.00), less than Zai Lab Limited (-10.47), greater than CG Oncology, Inc. Common stock (-26.96), greater than Scholar Rock Holding Corporation (-13.76), greater than Travere Therapeutics, Inc. (-223.18), greater than Legend Biotech Corporation (-26.49),
| Company | PE Ratio | Market cap |
|---|---|---|
| -24.33 | $6.15B | |
| -22.41 | $5.47B | |
| -8.95 | $1.64B | |
| -4.02 | $2.40B | |
| -25.00 | $4.32B | |
| -10.47 | $1.92B | |
| -26.96 | $5.25B | |
| -13.76 | $5.29B | |
| -223.18 | $4.84B | |
| -26.49 | $6.63B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xenon Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Xenon Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Xenon Pharmaceuticals Inc.'s PE Ratio?
How is the PE Ratio calculated for Xenon Pharmaceuticals Inc. (XENE)?
What is the highest PE Ratio for Xenon Pharmaceuticals Inc. (XENE)?
What is the 3-year average PE Ratio for Xenon Pharmaceuticals Inc. (XENE)?
What is the 5-year average PE Ratio for Xenon Pharmaceuticals Inc. (XENE)?
How does the current PE Ratio for Xenon Pharmaceuticals Inc. (XENE) compare to its historical average?